1. Home
  2. WHG vs NERV Comparison

WHG vs NERV Comparison

Compare WHG & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$19.20

Market Cap

185.2M

Sector

Finance

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$3.25

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
NERV
Founded
1983
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
166.4M
IPO Year
2002
2014

Fundamental Metrics

Financial Performance
Metric
WHG
NERV
Price
$19.20
$3.25
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.33
AVG Volume (30 Days)
11.0K
★ 113.5K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 3.16%
N/A
EPS Growth
★ 203.85
N/A
EPS
★ 0.25
N/A
Revenue
★ $97,762,000.00
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$76.00
★ N/A
Revenue Growth
★ 3.21
N/A
52 Week Low
$14.70
$2.24
52 Week High
$20.97
$12.46

Technical Indicators

Market Signals
Indicator
WHG
NERV
Relative Strength Index (RSI) 53.40 35.12
Support Level $18.87 N/A
Resistance Level $20.26 $4.73
Average True Range (ATR) 0.46 0.24
MACD 0.06 -0.00
Stochastic Oscillator 72.17 15.92

Price Performance

Historical Comparison
WHG
NERV

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: